Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis

Author： Avritscher Elenir  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.12, Iss.7, 2004-07, pp. : 531-536

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Dalteparin, a Kind of Low Molecular Weight Heparin, on Lung Adenocarcinoma A549 Cell Line In Vitro

By Chen Xiaojun   Xiao Wei   Qu Xun   Zhou Shengyu  

Cancer Investigation, Vol. 26, Iss. 7, 2008-08 ,pp. : 718-724

Informa Healthcare

Access to resources Recommend Favorite

Anti-metastasis efficacy and safety of non-anticoagulant heparin derivative versus low molecular weight heparin in surgical pancreatic cancer models

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 1225-1231

Spandidos Publications

Access to resources Recommend Favorite

Low molecular weight heparin suppresses tissue factor-mediated cancer cell invasion and migration in vitro

By            

Experimental and Therapeutic Medicine, Vol. 2, Iss. 2, 2011-01 ,pp. : 363-367

Spandidos Publications

Access to resources Recommend Favorite

The Effect of Low Molecular Weight Heparin Thromboprophylaxis on Bleeding Complications After Gastric Cancer Surgery

By Jeong Oh  

Annals of Surgical Oncology, Vol. 17, Iss. 9, 2010-09 ,pp. : 2363-2369

Springer Publishing Company

Access to resources Recommend Favorite

Combination therapy with low molecular weight heparin and Adriamycin results in decreased breast cancer cell metastasis in C3H mice

By        

Experimental and Therapeutic Medicine, Vol. 8, Iss. 4, 2014-01 ,pp. : 1213-1218

Spandidos Publications

Access to resources Recommend Favorite